Peter Morgan Kash
Director/Board Member at HEAE CAPI
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David Tanen | M | 52 |
Paramount BioCapital, Inc.
 Paramount BioCapital, Inc. Investment ManagersFinance Paramount BioCapital, Inc. is an alternative investment manager. The private company is based in New York, NY and has subsidiaries in the United States.
Two River Group Management LLC
Riverbank Capital Securities, Inc.
 Riverbank Capital Securities, Inc. Investment Banks/BrokersFinance Part of Two River Group Holdings LLC, Riverbank Capital Securities, Inc. deals securities. The company is based in New York, NY.
Danube Pharmaceuticals, Inc.
 Danube Pharmaceuticals, Inc. BiotechnologyHealth Technology Danube Pharmaceuticals, Inc. provides bio pharmaceutical services. It engages in the discovery and development of therapies and devices for ophthalmology. The firm's products include DNB-001, a small molecule for the treatment of glaucoma. The company was founded in 2006 and is headquartered in New York, NY.
Kirax Corp.
 Kirax Corp. Pharmaceuticals: MajorHealth Technology Kirax Corp. researches, develops, manufactures and distributes pharmaceutical products. The firm provides specialty care therapies to treat oncology, pain, inflammation, acute, and supportive care areas of unmet medical need. The company was founded by Mark E. Pruzanski, David M. Tanen and Edmundo Muniz in 2005 and is headquartered in Bonita Springs, FL. | 28 years |
| Joshua Kazam | M | 47 |
Paramount BioCapital, Inc.
Paramount BioCapital, Inc. Investment ManagersFinance Paramount BioCapital, Inc. is an alternative investment manager. The private company is based in New York, NY and has subsidiaries in the United States.
Riverbank Capital Securities, Inc.
Riverbank Capital Securities, Inc. Investment Banks/BrokersFinance Part of Two River Group Holdings LLC, Riverbank Capital Securities, Inc. deals securities. The company is based in New York, NY.
Danube Pharmaceuticals, Inc.
Danube Pharmaceuticals, Inc. BiotechnologyHealth Technology Danube Pharmaceuticals, Inc. provides bio pharmaceutical services. It engages in the discovery and development of therapies and devices for ophthalmology. The firm's products include DNB-001, a small molecule for the treatment of glaucoma. The company was founded in 2006 and is headquartered in New York, NY.
Kirax Corp.
Kirax Corp. Pharmaceuticals: MajorHealth Technology Kirax Corp. researches, develops, manufactures and distributes pharmaceutical products. The firm provides specialty care therapies to treat oncology, pain, inflammation, acute, and supportive care areas of unmet medical need. The company was founded by Mark E. Pruzanski, David M. Tanen and Edmundo Muniz in 2005 and is headquartered in Bonita Springs, FL. | 25 years |
| Edmundo Manuel Muniz | M | 68 |
Kirax Corp.
Kirax Corp. Pharmaceuticals: MajorHealth Technology Kirax Corp. researches, develops, manufactures and distributes pharmaceutical products. The firm provides specialty care therapies to treat oncology, pain, inflammation, acute, and supportive care areas of unmet medical need. The company was founded by Mark E. Pruzanski, David M. Tanen and Edmundo Muniz in 2005 and is headquartered in Bonita Springs, FL. | 19 years |
| Zvi Ben-David | M | 63 | 9 years | |
| Howard Marks | M | 77 |
University of Pennsylvania
| 24 years |
| Bruce Edward Roberts | M | 59 | 3 years | |
| William Johns | M | 65 | - | |
| Thomas Insel | M | 72 | 3 years | |
| Hila Karah | F | 55 | 10 years | |
| Esteban Pombo-Villar | M | - |
Targimmune Therapeutics AG
 Targimmune Therapeutics AG Pharmaceuticals: MajorHealth Technology Targimmune Therapeutics AG engages in the drug development using novel targeted onco-immunotherapies. The company was founded by Andreas Emmenegger and Peter Kash and is headquartered in Basel, Switzerland. | - |
| Andreas Emmenegger | M | 58 |
Targimmune Therapeutics AG
Targimmune Therapeutics AG Pharmaceuticals: MajorHealth Technology Targimmune Therapeutics AG engages in the drug development using novel targeted onco-immunotherapies. The company was founded by Andreas Emmenegger and Peter Kash and is headquartered in Basel, Switzerland. | - |
| Yordak Salermo | M | - |
Danube Pharmaceuticals, Inc.
Danube Pharmaceuticals, Inc. BiotechnologyHealth Technology Danube Pharmaceuticals, Inc. provides bio pharmaceutical services. It engages in the discovery and development of therapies and devices for ophthalmology. The firm's products include DNB-001, a small molecule for the treatment of glaucoma. The company was founded in 2006 and is headquartered in New York, NY. | - |
| Raphael Amit | M | 77 |
University of Pennsylvania
| 25 years |
| Christoph Rentsch | M | 65 |
Targimmune Therapeutics AG
Targimmune Therapeutics AG Pharmaceuticals: MajorHealth Technology Targimmune Therapeutics AG engages in the drug development using novel targeted onco-immunotherapies. The company was founded by Andreas Emmenegger and Peter Kash and is headquartered in Basel, Switzerland. | - |
| Stephen Buckley | M | - | 4 years | |
| Alex Fässler | M | 69 |
Targimmune Therapeutics AG
Targimmune Therapeutics AG Pharmaceuticals: MajorHealth Technology Targimmune Therapeutics AG engages in the drug development using novel targeted onco-immunotherapies. The company was founded by Andreas Emmenegger and Peter Kash and is headquartered in Basel, Switzerland. | - |
| Alexander Levitzki | M | - |
Targimmune Therapeutics AG
Targimmune Therapeutics AG Pharmaceuticals: MajorHealth Technology Targimmune Therapeutics AG engages in the drug development using novel targeted onco-immunotherapies. The company was founded by Andreas Emmenegger and Peter Kash and is headquartered in Basel, Switzerland. | - |
| Kuno Sommer | M | 68 |
Targimmune Therapeutics AG
Targimmune Therapeutics AG Pharmaceuticals: MajorHealth Technology Targimmune Therapeutics AG engages in the drug development using novel targeted onco-immunotherapies. The company was founded by Andreas Emmenegger and Peter Kash and is headquartered in Basel, Switzerland. | 7 years |
| Paolo Fundarò | M | 50 |
Targimmune Therapeutics AG
Targimmune Therapeutics AG Pharmaceuticals: MajorHealth Technology Targimmune Therapeutics AG engages in the drug development using novel targeted onco-immunotherapies. The company was founded by Andreas Emmenegger and Peter Kash and is headquartered in Basel, Switzerland. | 4 years |
| Mark Pruzanski | M | 56 |
Kirax Corp.
Kirax Corp. Pharmaceuticals: MajorHealth Technology Kirax Corp. researches, develops, manufactures and distributes pharmaceutical products. The firm provides specialty care therapies to treat oncology, pain, inflammation, acute, and supportive care areas of unmet medical need. The company was founded by Mark E. Pruzanski, David M. Tanen and Edmundo Muniz in 2005 and is headquartered in Bonita Springs, FL. | 19 years |
| Paul Anthony Mieyal | M | 55 |
Danube Pharmaceuticals, Inc.
Danube Pharmaceuticals, Inc. BiotechnologyHealth Technology Danube Pharmaceuticals, Inc. provides bio pharmaceutical services. It engages in the discovery and development of therapies and devices for ophthalmology. The firm's products include DNB-001, a small molecule for the treatment of glaucoma. The company was founded in 2006 and is headquartered in New York, NY. | - |
| Mark Dana Zand | M | 70 |
Danube Pharmaceuticals, Inc.
Danube Pharmaceuticals, Inc. BiotechnologyHealth Technology Danube Pharmaceuticals, Inc. provides bio pharmaceutical services. It engages in the discovery and development of therapies and devices for ophthalmology. The firm's products include DNB-001, a small molecule for the treatment of glaucoma. The company was founded in 2006 and is headquartered in New York, NY. | - |
| David Guyer | M | 64 |
Danube Pharmaceuticals, Inc.
Danube Pharmaceuticals, Inc. BiotechnologyHealth Technology Danube Pharmaceuticals, Inc. provides bio pharmaceutical services. It engages in the discovery and development of therapies and devices for ophthalmology. The firm's products include DNB-001, a small molecule for the treatment of glaucoma. The company was founded in 2006 and is headquartered in New York, NY. | - |
| David Milch | M | 68 | - | |
| Tim McInerney | M | 63 |
Riverbank Capital Securities, Inc.
Riverbank Capital Securities, Inc. Investment Banks/BrokersFinance Part of Two River Group Holdings LLC, Riverbank Capital Securities, Inc. deals securities. The company is based in New York, NY. | 17 years |
| Neil William Flanzraich | M | 80 |
Kirax Corp.
Kirax Corp. Pharmaceuticals: MajorHealth Technology Kirax Corp. researches, develops, manufactures and distributes pharmaceutical products. The firm provides specialty care therapies to treat oncology, pain, inflammation, acute, and supportive care areas of unmet medical need. The company was founded by Mark E. Pruzanski, David M. Tanen and Edmundo Muniz in 2005 and is headquartered in Bonita Springs, FL. | 14 years |
| Phyllis Gardner | M | 73 | 4 years | |
| Elizabeth P. Munson | F | 67 |
Cancer Schmancer Foundation
| - |
| Peter Braun | M | - |
Targimmune Therapeutics AG
Targimmune Therapeutics AG Pharmaceuticals: MajorHealth Technology Targimmune Therapeutics AG engages in the drug development using novel targeted onco-immunotherapies. The company was founded by Andreas Emmenegger and Peter Kash and is headquartered in Basel, Switzerland. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Glenn Mattes | M | 68 | 3 years | |
| Alexander Zukiwski | M | 65 | - | |
| Oren Fuerst | M | 51 | 3 years | |
| Stephen Rocamboli | M | 52 |
Paramount BioCapital, Inc.
Paramount BioCapital, Inc. Investment ManagersFinance Paramount BioCapital, Inc. is an alternative investment manager. The private company is based in New York, NY and has subsidiaries in the United States. | 8 years |
| Tae Yamaura | F | - |
University of Pennsylvania
| 2 years |
| Tomer Kariv | M | 62 | 7 years | |
| Scott Fields | M | 69 | 2 years | |
| Brian Lenz | M | 51 | 2 years | |
| Peter M. Lamb | M | - |
University of Pennsylvania
| 3 years |
| Yacov Reizman | M | 72 | - | |
| Alex Abell | M | - |
University of Pennsylvania
| 4 years |
| Nehal Kamalapat Chopra | F | - |
University of Pennsylvania
| 4 years |
| César Orosco | M | - |
University of Pennsylvania
| 6 years |
| Bill Belleville | M | - |
University of Pennsylvania
| 2 years |
| Joel Lloyd Gantcher | M | - |
University of Pennsylvania
| 2 years |
| Helen Remeza | M | - |
University of Pennsylvania
| 5 years |
| Andreas D. Olofsson | M | - |
University of Pennsylvania
| 5 years |
| Manny Yanez | M | - |
University of Pennsylvania
| 8 years |
| Sassan Alizadeh | M | - |
University of Pennsylvania
| 7 years |
| Simón Gaviria Muñoz | M | 43 |
University of Pennsylvania
| 4 years |
| Vijay Chattha | M | - |
University of Pennsylvania
| 5 years |
| Sean Evan Wright | M | 50 |
University of Pennsylvania
| 2 years |
| Robert Doebele | M | 53 |
University of Pennsylvania
| 4 years |
| Maja Sliwinski | F | - |
University of Pennsylvania
| 6 years |
| Thomas Pologruto | M | - |
University of Pennsylvania
| 4 years |
| Robert Buccigrossi | M | - |
University of Pennsylvania
| 4 years |
| J. Chris Houchins | M | 61 | 5 years | |
| Nachi Gupta | M | - |
University of Pennsylvania
| 3 years |
| Robert J. Fioretti | M | - |
University of Pennsylvania
| 12 years |
| James S. Riepe | M | - |
University of Pennsylvania
| 4 years |
| Saam Farhang | M | - |
University of Pennsylvania
| 5 years |
| Vijai P. Mohan | M | - |
University of Pennsylvania
| 5 years |
| Chuck Myers | M | - |
University of Pennsylvania
| 5 years |
| David M. Hollond | M | - |
University of Pennsylvania
| 2 years |
| Mehul Trivedi | M | 53 |
University of Pennsylvania
| 9 years |
| Doug Asiello | M | 54 |
University of Pennsylvania
| 3 years |
| Steven Ruchefsky | M | 61 | - | |
| Charles Hebard | M | - |
University of Pennsylvania
| 11 years |
| William F. Hamilton | M | 84 | - | |
| David A. Cohen | M | - |
University of Pennsylvania
| 13 years |
| Salvatore Tirabassi | M | - |
University of Pennsylvania
| 3 years |
| Filbert Cua | M | - |
University of Pennsylvania
| 4 years |
| Benjamin Levy | M | - |
University of Pennsylvania
| 4 years |
| Roger Egan | M | - |
University of Pennsylvania
| 4 years |
| Devesh Sharad Gandhi | M | - |
University of Pennsylvania
| 2 years |
| Richard Pulik | M | - |
University of Pennsylvania
| 4 years |
| Terrence Demorest | M | - |
University of Pennsylvania
| 4 years |
| Betsy George | F | - |
University of Pennsylvania
| 4 years |
| Liz A. Chang | F | - |
University of Pennsylvania
| 56 years |
| Wendell Pritchett | M | 59 |
University of Pennsylvania
| 3 years |
| Gregg Gilbert | M | - |
University of Pennsylvania
| 4 years |
| Jeffrey P. Gerson | M | - |
University of Pennsylvania
| 4 years |
| Anthony Cambeiro | M | - |
University of Pennsylvania
| 4 years |
| Wen Kai Xiang | M | - |
University of Pennsylvania
| 4 years |
| Jason S. Kahan | M | - |
University of Pennsylvania
| 4 years |
| Ed Zane | M | - |
University of Pennsylvania
| 4 years |
| Jonathan Tower | M | - |
University of Pennsylvania
| 2 years |
| Thuy Tran | M | - |
University of Pennsylvania
| 2 years |
| Elizabeth Marie Bernstein | F | - |
University of Pennsylvania
| 4 years |
| Lloyd Sommers | M | - |
University of Pennsylvania
| 4 years |
| Jonathan G. Marymor | M | - |
University of Pennsylvania
| 4 years |
| Sabir J. Rassiwalla | M | - |
University of Pennsylvania
| 4 years |
| Mei Qing Ren | F | - |
University of Pennsylvania
| 2 years |
| Arun Rao | M | - |
University of Pennsylvania
| 4 years |
| Atul Joshi | M | - |
University of Pennsylvania
| 4 years |
| Sean E. Epps | M | 55 |
University of Pennsylvania
| 2 years |
| Shreyas Devkumar Gupta | M | 50 |
University of Pennsylvania
| 4 years |
| Joseph Galone | M | - |
University of Pennsylvania
| 4 years |
| Andrew McCormack | M | - |
University of Pennsylvania
| 4 years |
| Lily Ng | F | - |
University of Pennsylvania
| 4 years |
| Greg T. Pusch | M | - |
University of Pennsylvania
| 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 90 | 90.00% |
| Switzerland | 8 | 8.00% |
| Australia | 2 | 2.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Peter Morgan Kash
- Personal Network
